We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue.
Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.
Biotechnology Research, Biotechnology research and development, Research and testing, IT, Internet, R&D, Scientific Research and Development Services, Services